/NOT FOR DISSEMINATION IN THE UNITED STATES OR THROUGH U.S.
NEWSWIRES/
TORONTO, Sept. 20, 2018 /CNW/ - TerrAscend Corp.
(CSE:TER) ("TerrAscend" or the "Company") today announced that the Company's wholly-owned subsidiary, Solace Health
Network Inc. ("Solace Health Network"), has entered into an agreement with MCI Medical Clinics Inc. ("MCI") to
provide medical cannabis services.
Solace Health Network is a medical education and support program with a focus on patient care through quality medical cannabis
education, patient services and cannabinoid treatment plans. MCI is one of the largest primary medical care groups in
Canada with twenty-six clinics located across the country with over two million registered
patients.
"With Solace Health Network, patients have the option to meet with healthcare professionals and educators, either in-person
or through a telehealth consultation from the convenience and privacy of a home environment." said Sabrina Ramkellawan, VP of Clinical Affairs at TerrAscend. "We have been working on numerous cannabinoid
research initiatives with the goal of building a body of evidence to guide clinical education and support. With this agreement,
these services will now be available to MCI patients at their clinic network."
Under the terms of the agreement, Solace Health Network will become the exclusive partner for MCI, providing MCI patients with
access to expertise, services and information, as well as ongoing clinical and reimbursement support. Solace Health Network
offers specialized services to meet the evolving needs of patients, including condition-specific treatment plans to assist
patients with dose and strain selection as well as guidance through wellness plans for non-pharmacological treatments.
"On behalf of our expansive patient clinics throughout Alberta and Ontario, we are delighted to have selected Solace Health Network as our partner to serve patients with
medical cannabis services" said Maddie Walker, President of MCI. "We are confident that
their services of assessing, treating and managing patient needs for medical cannabis will provide an added and requested
competency to our medical network."
About TerrAscend
TerrAscend is a biopharmaceutical and wellness company that is committed to quality products, brands and services for the
global cannabinoid market. The Company provides support to medical consumers through its wholly-owned subsidiaries, Solace Health
Inc., a licensed producer of medical cannabis under the Access to Cannabis for Medical Purposes Regulations and Solace Health
Network Inc., a clinical support program and education platform led by healthcare professionals.
Forward Looking Information
This news release contains "forward-looking information" within the meaning of applicable securities laws. Although
TerrAscend believes in light of the experience of its officers and directors, current conditions and expected future developments
and other factors that have been considered appropriate, that the expectations reflected in this forward-looking information are
reasonable, undue reliance should not be placed on them because TerrAscend can give no assurance that they will prove to be
correct. Readers are cautioned to not place undue reliance on forward-looking information. Actual results and developments may
differ materially from those contemplated by these statements. The statements in this press release are made as of the date of
this release. TerrAscend undertakes no obligation to comment on analyses, expectations or statements made by third-parties in
respect of TerrAscend, its securities, or financial or operating results (as applicable). TerrAscend disclaims any intent or
obligation to update publicly any forward-looking information, whether as a result of new information, future events or results
or otherwise, other than as required by applicable securities laws.
Related Link:
www.TerrAscend.com.
SOURCE TerrAscend
View original content to download multimedia: http://www.newswire.ca/en/releases/archive/September2018/20/c4334.html